How is cosentyx dosage adjusted for obese patients?

Is the Cosentyx dose the same in obese patients?

Yes. Cosentyx (secukinumab) dosing is not adjusted based on body weight or obesity. The labeled dosing regimen is used regardless of whether a patient is obese. [1]

What dosing schedule does Cosentyx use (including for people with higher body weight)?

The regimen depends on the condition being treated. For plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, the usual adult dosing schedules follow the standard label titration/maintenance steps rather than weight-based changes. [1]

Why don’t labels change dosing by weight for obesity?

The product information does not describe any obesity-specific dose adjustment. That means clinicians follow the condition-specific labeled dose and monitor response rather than using weight to change the amount. [1]

What should patients ask their clinician if response is weaker in obesity?

Because obesity is not a dosing variable in the label, the practical approach is to assess treatment response and adherence, then discuss whether to adjust the treatment plan (for example, switching therapy) if disease control is inadequate. The label-supported starting dose remains the same. [1]

Sources

1. Cosentyx (secukinumab) prescribing information (dosage and administration). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm